富罗塞米德降低产前严重高血压:一个随机的安慰剂对照试验
Melanie M Maykin1, Elizabeth Mercer1, Kevin M Saiki1
1Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine of the University of Hawaii, Honolulu, HI.
American journal of obstetrics & gynecology MFM
|March 14, 2024
概括
将静脉注射的罗塞米德添加到抗高血压药物中并没有立即降低严重产前高血压的缩血压. 然而,它确实在两小时后降低了血压和脉冲压,这表明它可能对体积扩大患者有益.
科学领域:
- 产科和妇科 产科和妇科
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 怀孕的高血压疾病是孕产妇和胎儿并发症的主要原因之一.
- 在怀孕期间有效管理严重高血压对于预防不良后果至关重要.
- 利尿剂在治疗急性产前高血压和血量增加中的作用尚未得到充分证实.
研究的目的:
- 为了确定是否添加静脉注射的罗西米德到一线抗高血压药物改善了严重产前高血压的静缩血压控制.
- 评估宽脉压 (≥60 mm Hg) 的患者对血压参数的影响.
主要方法:
- 一个双盲随机试验,涉及65名患有严重产前高血压的参与者.
- 参与者接受了静脉注射的富罗塞米德 (40毫克) 或安慰剂,以及标准的抗高血压剂.
- 主要结局是干预后第一小时内的平均静缩血压;次要结局包括2小时血压,脉冲压和尿液输出.
主要成果:
- 在弗洛塞米德和安慰剂组之间,在第一个小时内没有观察到平均静脉压的显著差异.
- 罗塞米德组在干预后2小时显著降低了缩血压和脉冲压.
- 发胺组的尿量增加,电解质或肌氨酸没有显著变化.
结论:
- 在治疗严重产前高血压的第一个小时内,静脉注射单剂量罗西米德并没有显著降低缩血压.
- 然而,罗西米德在2小时后对血压和脉冲压产生了有益影响,这表明它作为辅助治疗的实用性.
- 静脉注射的富洛塞米德可能是抗高血压药物方案的合理补充,特别是在怀孕期间怀疑体积过载的孕妇中.
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
680
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
680
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
534
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
534
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
625
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
625
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
446
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
446